Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here ...

The growth of the neurovascular devices market is largely fueled by the increasing burden of neurovascular disorders, rapid technological advancements in devices, a growing preference for minimally ...

Along with giving financial support to local community groups and charities, companies are also encouraging staff members to ...

Boston Scientific agreed to buy medtech firm Penumbra in a $14.5 billion deal on Thursday, its second‑largest takeover ever, ...

Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced that it has been awarded a contract ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

BAE Systems plc BAESY recently stated that it has secured a $184 million contract from the U.S. Marine Corps for the ...

Debt Management: Stryker's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.76, the ...

There’s a fresh face in HiSun’s electric UTV line-up, promising better performance, a slicker cab and a keener price tag than ...

Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Rodda brings more than 20 years of experience building, scaling, and exiting enterprise software companies. Across his career, he has driven four successful exits and raised over $80 million. Most ...